Nandan Diagnostics Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 5.00 M
- Company Age 5 Year, 10 Months
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 5.44 Cr
- Revenue Growth -10.36%
- Profit Growth -5.99%
- Ebitda -28.43%
- Net Worth -55.63%
- Total Assets -18.74%
About Nandan Diagnostics
Nandan Diagnostics Private Limited (NDPL) is a Private Limited Indian Non-Government Company incorporated in India on 02 April 2019 (Five years and ten months 24 days old ). Its registered office is in Karim Nagar, Telangana, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 5.00 M.
The company currently has active open charges totaling ₹5.44 Cr.
Vikas Thakur and Neeraj Tatipalli serve as directors at the Company.
Company Details
- Location
Karim Nagar, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U85320TG2019PTC131801
- Company No.
131801
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Apr 2019
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Nandan Diagnostics?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vikas Thakur  | Director | 02-Apr-2019 | Current |
| Neeraj Tatipalli | Director | 02-Apr-2019 | Current |
Financial Performance of Nandan Diagnostics.
Nandan Diagnostics Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 10.36% decrease. The company also saw a slight decrease in profitability, with a 5.99% decrease in profit. The company's net worth observed a substantial decline by a decrease of 55.63%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nandan Diagnostics?
In 2022, Nandan Diagnostics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sitamma Neurocriticare Private LimitedVikas Thakur is a mutual person
- Ssrn Manufacturers And Services Private Limited
Neeraj Tatipalli is a mutual person
Charges (Loans)
₹54.40 M
₹0
Charges Breakdown by Lending Institutions
- Others : 5.44 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 07 Apr 2020 | Others | ₹5.44 Cr | Open |
How Many Employees Work at Nandan Diagnostics?
Unlock and access historical data on people associated with Nandan Diagnostics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nandan Diagnostics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nandan Diagnostics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.